SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-007110
Filing Date
2023-03-06
Accepted
2023-03-06 06:15:10
Documents
1
Period of Report
2023-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10247
  Complete submission text file 0000899243-23-007110.txt   13157
Mailing Address 6-8 DOSHOMACHI 2-CHOME CHUO-KU OSAKA M0 541-0045
Business Address 6-8 DOSHOMACHI 2-CHOME CHUO-KU OSAKA M0 541-0045 816-6203-5321
Sumitomo Pharma Co., Ltd. (Reporting) CIK: 0001446601 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 23707473

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ROIVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB (646) 802-3660
Sumitovant Biopharma Ltd. (Reporting) CIK: 0001798244 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 23707472

Mailing Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020
Business Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020 813-5201-0222
Sumitomo Chemical Co., Ltd. (Reporting) CIK: 0001798550 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 23707474